Cargando…

2280. Bloodstream Klebsiella pneumonia Infection and Carbapenem Combination Treatment Regimen in High-Dose Vasopressor-Dependent Septic Shock

BACKGROUND: The clinical effectiveness of the double-carbapenem combination therapy in mechanically ventilated patients with carbapenemase-producing carbapenem-resistant Enterobacteriaceae bloodstream septic shock infection is not well studied. METHODS: Over a 4-year period (2013–2017), critically i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magira, Eleni, Perlikos, Fotis, Kokkoris, Stelios, Zakynthinos, Spyros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810659/ http://dx.doi.org/10.1093/ofid/ofz360.1958

Ejemplares similares

PEEP levels in COVID-19 pneumonia
por: Tsolaki, Vasiliki, et al.
Publicado: (2020)

Fewer Intubations but Higher Mortality Among Intubated Coronavirus Disease 2019 Patients During the Second Than the First Wave
por: Routsi, Christina, et al.
Publicado: (2021)

Current use of vasopressors in septic shock
por: Scheeren, Thomas W. L., et al.
Publicado: (2019)

Vasopressors in Septic Shock: The Quest for Refinement
por: Pichamuthu, Kishore
Publicado: (2022)

Choice of vasopressor in septic shock: does it matter?
por: Patel, Gourang P, et al.
Publicado: (2007)

Fluids or vasopressors for the initial resuscitation of septic shock
por: Macdonald, Stephen, et al.
Publicado: (2022)

Influence of vasopressor agent in pediatric septic shock mortality
por: Mangia, CMF, et al.
Publicado: (2011)

Vasopressors in septic shock: which, when, and how much?
por: Shi, Rui, et al.
Publicado: (2020)

Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis
por: Avni, Tomer, et al.
Publicado: (2015)

Outcome of patients with septic shock and high-dose vasopressor therapy
por: Auchet, Thomas, et al.
Publicado: (2017)

Should we start vasopressors very early in septic shock?
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2020)

Early versus delayed vasopressor administration in patients with septic shock
por: Abe, Toshikazu, et al.
Publicado: (2023)

Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity?
por: Hartemink, Koen J., et al.
Publicado: (2011)

Timing of vasopressor initiation and mortality in septic shock: a cohort study
por: Beck, Vance, et al.
Publicado: (2014)

Vasopressors in septic shock: a systematic review and network meta-analysis
por: Zhou, Feihu, et al.
Publicado: (2015)

Effect of high-dose Ascorbic acid on vasopressor's requirement in septic shock
por: Zabet, Mohadeseh Hosseini, et al.
Publicado: (2016)

Time to vasopressor initiation and organ failure progression in early septic shock
por: Black, Lauren Page, et al.
Publicado: (2020)

Management of Vasopressor-Induced Acute Limb Ischemia (VIALI) in Septic Shock
por: Attallah, Noura, et al.
Publicado: (2022)

The Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock
por: Hamzaoui, Olfa, et al.
Publicado: (2023)

744. Antifungal De-escalation Strategy in ICU Patients: Clinical Success and Cost Savings
por: magira, Eleni, et al.
Publicado: (2019)

Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes
por: Yuan, Youhua, et al.
Publicado: (2020)

COLLABORATION AGREEMENT KE2280/GS
por: THE NATIONAL RESEARCH NUCLEAR UNIVERSITY MEPhI, RUSSIA, et al.
Publicado: (2013)

Using the diastolic shock index to determine when to promptly administer vasopressors in patients with septic shock
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2022)

Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock
por: Ray, David Charles, et al.
Publicado: (2007)

Mortality rate of vasopressor-dependent septic shock from 1997 through 2006
por: Afessa, B, et al.
Publicado: (2009)

Broad spectrum vasopressors: a new approach to the initial management of septic shock?
por: Chawla, Lakhmir S., et al.
Publicado: (2019)

Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Klebsiella pneumoniae in China
por: Liang, Xiaoxue, et al.
Publicado: (2022)

Development and performance of a novel vasopressor-driven mortality prediction model in septic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2018)

Adjunctive Vasopressors in Patients with Septic Shock: Protocol for a Systematic Review and Meta-Analysis
por: Bauer, Seth R., et al.
Publicado: (2023)

Weaning failure of cardiovascular origin: how to suspect, detect and treat—a review of the literature
por: Routsi, Christina, et al.
Publicado: (2019)

Septic shock and vasopressor requirement is associated with lower vitamin D levels in critically ill children
por: Madden, K, et al.
Publicado: (2011)

The evaluation of perfusion index as a predictor of vasopressor requirement in patient with sever sepsis and septic shock
por: Rasmy, I, et al.
Publicado: (2015)

Esophageal and Gastroduodenal Hemorrhagic Necrosis: A Unique Finding in the Setting of Septic Shock and Vasopressor Use
por: Carvão, Joana, et al.
Publicado: (2018)

Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial
por: Petsakul, Suttasinee, et al.
Publicado: (2020)

Bundle Adherence of Intravenous Antibiotic Fluid Resuscitation and Vasopressor in Children with Severe Sepsis or Septic Shock
por: Barboza, Clarice L, et al.
Publicado: (2020)

Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients
por: Kilian, Scott, et al.
Publicado: (2022)

Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review
por: Zhou, Hang-Xiang, et al.
Publicado: (2023)

Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?
por: Carlos Sanchez, E., et al.
Publicado: (2023)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
por: Liang, Qiqiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_38s9nt487tp223o374a4656l5i